Cost and Cost-Effectiveness of Treatment Delivery
Over the past decade, international agencies and national governments have set ambitious targets for the delivery of effective care and treatment for HIV⁄AIDS in resource-constrained countries. Treatment is already consuming a large proportion of national health budgets and international donor assistance, and warnings have begun to emerge of an impending funding shortfall in many countries. The goal of the CGHD’s research in this area is to estimate the outcomes, costs, and cost-effectiveness of adult and pediatric antiretroviral therapy (ART) for HIV/AIDS in different settings, at different scales, and under different models of treatment delivery. Understanding the relationship between cost of treatment and its outcomes is essential to long-term planning and financing of national treatment programs.